Regional spread of Pseudomonas aeruginosa ST357 producing IMP-7 metallo-β-lactamase in Central Europe

Journal of Clinical Microbiology

Volumn 49, Issue 1, 2011, Pages 474-475

  Hrabák, Jaroslav ^a   Červená, Dana ^a   Izdebski, Radoslaw ^b   Duljasz, Wojciech ^b   Gniadkowski, Marek ^b   Fridrichová, Marta ^c   Urbášková, Pavla ^c   Žemličková, Helena ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b NATIONAL MEDICINES INSTITUTE   (Poland)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BACTERIAL ENZYME; CEFEPIME; CEFOPERAZONE; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; EDETIC ACID; GENOMIC DNA; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CZECH REPUBLIC; DRUG HYDROLYSIS; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; EUROPE; GENE CASSETTE; LETTER; NONHUMAN; NUCLEOTIDE SEQUENCE; POLAND; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; SPECTROPHOTOMETRY;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; DNA, BACTERIAL; EUROPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MULTILOCUS SEQUENCE TYPING; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEQUENCE ANALYSIS, DNA;

PSEUDOMONAS AERUGINOSA;

EID: 78650897185     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00684-10     Document Type: Letter

References (20)

1. Cardoso, O., R. Leitão, A. Figueiredo, J. C. Sousa, A. Duarte, and L. Peixe. 2002. Metallo-β-lactamase VIM-2 in clinical isolates of Pseudomonas aeruginosa from Portugal. Microb. Drug Resist. 8:93-97.
2. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing, nineteenth informational supplement. Document M100-S19. CLSI, Wayne, PA.
3. Curran, B., D. Jonas, H. Grundmann, T. Pitt, and C. G. Dowson. 2004. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J. Clin. Microbiol. 42:5644-5649.
4. Ellington, M. J., J. Kistler, D. M. Livermore, and N. Woodford. 2007. Multiplex PCR for rapid detection of genes encoding acquired metallo-β-lactamases. J. Antimicrob. Chemother. 59:321-322.
5. Fiett, J., A. Baraniak, A. Mrówka, M. Fleischer, Z. Drulis-Kawa, Ł. Naumiuk, A. Samet, W. Hryniewicz, and M. Gniadkowski. 2006. Molecular epidemiology of the acquired metallo-β-lactamase-producing bacteria in Poland. Antimicrob. Agents Chemother. 50:880-886.
6. Gib, A. P., C. Trbuddharat, R. A. Moore, T. J. Louie, W. Krulicki, D. M. Livermore, M.-F. Palepou, and N. Woodford. 2002. Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new blaIMP allele, blaIMP-7. Antimicrob. Agents Chemother. 46:255-258.
7. Ho, S. E., G. Subramaniam, S. Palasubramaniam, and P. Navaratnam. 2002. Carbapenem-resistant Pseudomonas aeruginosa in Malaysia producing IMP-7 β-lactamase. Antimicrob. Agents Chemother. 46:3286-3287.
8. Hrabák, J., M. Fridrichová, M. Štolbová, T. Bergerová, H. Zemlickova, and P. Urbášková. 2009. First identification of metallo-β-lactamase-producing Pseudomonas aeruginosa in the Czech Republic. Euro Surveill. 14:19102.
9. Jolley, K. A., M. S. Chan, and M. C. Maiden. 2004. mlstdbNet - distributed multi-locus sequence typing (MLST) databases. BMC Bioinformatics 5:86.
10. IMP-7 in a Pseudomonas aeruginosa in Japan. J. Infect. Chemother. 13:276-277.
11. Lee, K., Y. S. Lim, D. Yong, J. H. Yum, and Y. Chong. 2003. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 41:4623-4629.
12. Ohlasova, D., V. Kmet, and M. Niks. 2007. First report of the carbapenem-resistant Pseudomonas aeruginosa producing IMP-7 metallo-β- lactamase in Slovakia. Int. J. Antimicrob. Agents 30:370-371.
13. VIM-4 gene cassette isolated from hospitalized children in Poland (1998-2001). J. Antimicrob. Chemother. 53:451-456.
14. Patzer, J. A., T. R. Walsh, J. Weeks, D. Dzierżanowska, and M. A. Toleman. 2009. Emergence and persistence of integron structures harbouring VIM genes in the Children's Memorial Health Institute, Warsaw, Poland, 1998-2006. J. Antimicrob. Chemother. 63:269-273.
15. Poirel, L., J. D. Pitout, and P. Nordmann. 2007. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol. 2:501-512.
16. Queenan, A. M., and K. Bush. 2007. Carbapenemases: the versatile β-lactamases. Clin. Microbiol. Rev. 20:440-458.
17. Rossolini, G. M., F. Luzzaro, R. Migliavacca, C. Mugnaioli, B. Pini, F. De Luca, M. Perilli, S. Pollini, M. Spalla, G. Amicosante, A. Toniolo, and L. Pagani. 2008. First countrywide survey of acquired metallo-β-lactamases in gram-negative pathogens in Italy. Antimicrob. Agents Chemother. 52:4023-4029.
18. Struelens, M. J., F. Rost, A. Deplano, A. Maas, V. Schwam, E. Serruys, and M. Cremer. 1993. Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis. Am. J. Med. 95:489-498.
19. VIM-2 in Eastern Europe: report from the SENTRY Antimicrobial Surveillance Program. J. Antimicrob. Chemother. 52:116-119.
20. VIM-2 in clinical isolates of Pseudomonas aeruginosa. J. Med. Microbiol. 58:1080-1085.